Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113831366A discloses novel cinchona alkaloid ligands for high-efficiency asymmetric catalysis, offering superior stereoselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN103193830A reveals a flexible route for chiral ferrocene phosphine ligands, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Patent CN112939922B details a cost-effective synthesis route for a critical Mesotrione impurity, offering reliable supply chain solutions and high-purity standards for agrochemical registration.
Novel preparation method for Tezacaftor via reductive cyclization. High purity, low cost, scalable industrial process for API intermediates.
Novel BF3-catalyzed route offers high yields and metal-free purification for scalable API intermediate production.
Patent CN113373466A details a green electrochemical route for beta-acetaminocarbonyl compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112047797A reveals a green iridium-catalyzed method for alpha-alkyl ketones using water. Discover cost-effective manufacturing and supply advantages.
Patent CN112010896B reveals a green copper-catalyzed route for phosphonates, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN109705154B details a cobalt-catalyzed tandem hydrosilylation for synthesizing exo-gem-disilyl alkanes. This method offers superior regioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Patent CN116589519A reveals improved sulfonation and Suzuki coupling for high-purity API intermediate manufacturing with reduced corrosion risks and enhanced scalability.
Novel zinc-mediated route for Vilazodone intermediate. High yield, low waste, scalable production for pharma supply chains ensuring reliability and cost efficiency globally for all buyers.
Novel C7-position stereospecific method enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally using cost effective ruthenium catalysis.
Efficient ruthenium-catalyzed method reduces costs and environmental load for high-purity pharmaceutical intermediates manufacturing supply chain.
Patent CN107602408B reveals a copper-catalyzed air oxidation route for diethyl acetamidomalonate. This method offers high purity, recyclable catalysts, and significant supply chain cost advantages for pharmaceutical manufacturers.
Patent CN113024518A details a streamlined 3-step halogenation route for Erdafitinib, offering high purity and reduced costs for pharmaceutical manufacturers.
Novel cobalt-catalyzed route offers high optical purity for pharmaceutical intermediates. Streamlined process ensures supply chain reliability and cost efficiency for global buyers.
Novel preparation method avoids acyl chloride instability. Achieves >99.5% purity. Cost-effective API intermediate manufacturing solution for global supply chains.
Patent CN117510377A details a novel 4-step synthesis for high-purity Fmoc-Glu-OtBu. This method ensures cost reduction and supply chain reliability for peptide manufacturing.
Novel liquid-phase synthesis of 5-ester pyrazolines using soluble PEG resin. High purity, scalable process for drug discovery and agrochemical applications.